Evidence Insufficient To Compare Psoriatic Arthritis Drugs – AHRQ
Executive Summary
A comparative effectiveness study on drug therapies used to treat psoriatic arthritis in adults determined that the evidence is insufficient to draw any conclusions.
You may also be interested in...
NICE Gives Thumbs Down to Simponi--For Now
The controversial health technology assessment agency is unconvinced of the drug's cost benefit in a crowded market, which is already well served, and concerned about its long-term safety profile.
FDA 2015 Budget Increase Proposal Leans On Food Safety User Fees
Food safety programs would get the largest increase in the White House’s proposed fiscal 2015 FDA budget, and increases in user fee programs are proposed as key drivers for the boost. The agency’s overall budget would grow $335 million to $4.7 billion in the proposal.
FDA 2015 Budget Increase Proposal Leans On Food Safety User Fees
Food safety programs would get the largest increase in the White House’s proposed fiscal 2015 FDA budget, and increases in user fee programs are proposed as key drivers for the boost. The agency’s overall budget would grow $335 million to $4.7 billion in the proposal.